Bleranda Zeka
Impact in
- Pathology and Forensic Medicine top 10%
- Multiple Sclerosis Research Studies
- Neurology top 10%
- Peripheral Neuropathies and Disorders
- Neuroinflammation and Neurodegeneration Mechanisms
- Autoimmune Neurological Disorders and Treatments
Papers in
- Oncology 7
- Colorectal Cancer Treatments and Studies 4
- Cytokine Signaling Pathways and Interactions 1
-
- Hepatocellular Carcinoma Treatment and Prognosis 7
- Co-authors
- Hans Lassmann (5 shared papers)Monika Bradl (5 shared papers)Kathrin Schanda (4 shared papers)Markus Reindl (4 shared papers)Kazuo Fujihara (3 shared papers)Thomas Berger (1 shared paper)Tatsuro Misu (2 shared papers)Wendy B. Macklin (1 shared paper)
In The Last Decade
Bleranda Zeka
12 papers receiving 274 citations
Peers
Comparison fields: 5 of 52
- Pathology and Forensic Medicine 172
- Neurology 75
- Neurology 114
- Rheumatology 55
- Developmental Neuroscience 15
Countries citing papers authored by Bleranda Zeka
This map shows the geographic impact of Bleranda Zeka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bleranda Zeka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bleranda Zeka more than expected).
Fields of papers citing papers by Bleranda Zeka
This network shows the impact of papers produced by Bleranda Zeka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bleranda Zeka. The network helps show where Bleranda Zeka may publish in the future.
Co-authors
The 25 scholars most cited alongside Bleranda Zeka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 119 | |
| 2 | 2015 | 57 | |
| 3 | 2016 | 46 | |
| 4 | 2017 | 13 | |
| 5 | 2016 | 11 | |
| 6 | 2022 | 8 | |
| 7 | 2022 | 7 | |
| 8 | 2020 | 5 | |
| 9 | 2025 | 3 | |
| 10 | 2023 | 3 | |
| 11 | 2022 | 3 | |
| 12 | Proquinazid activates host defense gene expression in Arabidopsis thaliana. | 2008 | 1 |
| 13 | 2023 | 0 | |
| 14 | 2025 | 0 | |
| 15 | 2023 | 0 |
About Bleranda Zeka
Bleranda Zeka is a scholar working on Oncology, Hepatology, Surgery, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 15 papers that have together received 276 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Multiple Sclerosis Research Studies (5 papers), Colorectal Cancer Treatments and Studies (4 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Systemic Lupus Erythematosus Research (3 papers), Lung Cancer Treatments and Mutations (2 papers) and Cytokine Signaling Pathways and Interactions (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (172 citations), Neurology (75 citations), Neurology (114 citations), Rheumatology (55 citations) and Developmental Neuroscience (15 citations). Bleranda Zeka has collaborated with scholars based in Germany, Austria and France. Frequent co-authors include Hans Lassmann, Monika Bradl, Kathrin Schanda, Markus Reindl, Kazuo Fujihara, Thomas Berger, Tatsuro Misu, Wendy B. Macklin, Katherine S. Given and Patrick Peschl. Their work appears in journals such as CardioVascular and Interventional Radiology, Acta Neuropathologica Communications, Journal of Clinical Medicine, ESMO Open and Clinical Colorectal Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.